Large Cap Biotech Analyst Brayer, along with Richard Sanders, JD, Partner at Southern Health Lawyers, discuss the Inflation Reduction Act and potential implications from ongoing legal proceedings with Pharma/Industry Lobbyists (relevant companies JNJ, MRK, BMY) on an Analyst/Industry conference call to be held on August 17 at 10 am. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on JNJ:
- Johnson & Johnson says final exchange ratio 8.0324 in split-off of Kenvue
- Cantor biotech/biopharma analysts to hold analyst/industry conference call
- Notable open interest changes for August 16th
- Nanobiotix announces expiration of HSR antitrust waiting period for NBTXR3 pact
- Cantor Fitzgerald biotech analyst to hold an analyst/industry conference call